06.01.2013 Views

EURON and THEME joint PhD meeting

EURON and THEME joint PhD meeting

EURON and THEME joint PhD meeting

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

99<br />

<strong>EURON</strong> <strong>and</strong> <strong>THEME</strong> <strong>joint</strong> <strong>meeting</strong> 2011<br />

Brain-derived neurotrophic factor (BDNF), a bridge<br />

between depression <strong>and</strong> Alzheimer’s disease<br />

Tim Vanmierlo, Jochen De Vry, Caroline Hammels, Annerieke Sierksma, Denise<br />

Hermes, Harry Steinbusch <strong>and</strong> Jos Prickaerts.<br />

School for Mental Health <strong>and</strong> Neuroscience, Maastricht University, Maastricht, The Netherl<strong>and</strong>s<br />

There is ample evidence suggesting that a history of major depression constitutes a<br />

risk factor for the development of Alzheimer’s disease (AD) later in life. Decreased<br />

levels of the growth factor brain-derived neurotrophic factor (BDNF) play a key<br />

role in the reduced plasticity in the hippocampus of patients with depression as<br />

well as in patients with AD. We hypothesize that hippocampal overexpression<br />

of tropomyosine receptor kinase (TrkB), the high affinity receptor of BDNF, will<br />

attenuate <strong>and</strong> delay the onset of AD pathology. To test this hypothesis we used<br />

the APPswe/PS1dE9 mouse model of AD. Hippocampal TrkB overexpression<br />

was established via a current controlled stereotactic microelectroporation of a<br />

plasmid stably expressing TrkB at the start of AD pathology, i.e. plaques formation,<br />

at 6 months of age. Memory was scored at 7 months of age, when cognitive<br />

decline is expected to start, in the object location task, the Morris water escape<br />

maze <strong>and</strong> the spatial alteration Y-maze. In addition, depression <strong>and</strong> anxiety<br />

related behavior were respectively assessed in the sucrose preference test, the<br />

forced swim task <strong>and</strong> the elevated zero maze. Electroporation efficiency will be<br />

validated by immunohistochemistry (IHC). Manifestation of the AD pathology<br />

on the molecular level will be quantified by ELISA <strong>and</strong> IHC. First results showed<br />

surprisingly that TrkB overexpression in the hippocampus impaired object location<br />

memory in our AD mice. In contrast, depression–like behavior in the forced swim<br />

test was attenuated in these AD mice. No effects of TrkB overexpression were<br />

observed in wild-type control mice. Biochemical <strong>and</strong> IHC analyses are underway<br />

to further investigate this possible TrkB-mediated distinction in cognitive <strong>and</strong><br />

affective behavior in AD mice.

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!